Ángela R. Solano - Concepedia

Concepedia

Author

Ángela R. Solano

Universidad de Buenos Aires ORCID

Also Known As

Angela R Solano, Angela R. Solano, Angela Rosaria Solano, Angela Solano, Solano, Ángela, Ángela R. Solano, Ángela Solano

40

Publications

1.1K

Citations

18

H-Index

36

Concepts

All Affiliations

Universidad de Buenos Aires Consejo Nacional de Investigaciones Científicas y Técnicas Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno Instituto Alexander Fleming Rigshospitalet

ÁR

About

Ángela R. Solano is an author at Universidad de Buenos Aires specializing in medicine, pathology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	726
2	Biochemistry	2	2	211
3	Public Health	1	1	298
4	Cell Biology	1	1	111
5	Epidemiology	1	1	298

Ángela R. Solano

×

18

Publications

1.1K

Citations

17

H-Index

	Year	Citations
Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations Timothy R. Rebbeck, Tara M. Friebel, Eitan Friedman, Human Mutation Brca1 MutationsGenetic TestingGeneticsGenetic EpidemiologyMolecular Genetics	2018	298
Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer Ruta Sahasrabudhe, Paul C. Lott, Mábel Bohórquez, Gastroenterology Genome InstabilitySomatic VariantGastrointestinal OncologyGeneticsPathology	2016	126
Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer Cells Paula Maloberti, Alejandra Duarte, Ulises Orlando, PLoS ONE Breast OncologyFunctional InteractionMetabolic RemodelingCancer BiologyTumor Biology	2010	111
Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression Ulises Orlando, Ana F. Castillo, Mayra Agustina Ríos Medrano, Biochemical Pharmacology Signal TransductionEnergy-dependent Transporter ExpressionBiochemistryMolecular PathwayMedicine	2018	100
BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin Ángela R. Solano, Gitana María Aceto, Dreanina Delettieres, SpringerPlus	2012	58
Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer Ulises Orlando, Ana F. Castillo, Melina A. Dattilo, Oncotarget	2015	51
Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness Vivek Patel, Evan L. Busch, Tara M. Friebel, Cancer Research	2019	50
Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice Ángela R. Solano, Florencia C. Cardoso, Vanesa Romano, Oncotarget	2016	38
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer Gitana María Aceto, Ángela R. Solano, Maria Isabel Neuman, Breast Cancer Research and Treatment Juvenile Breast CancerTp53 StatusBreast OncologyMedicineImmunology	2009	33
First genotype characterization of Argentinean FAP patients: Identification of 14 novel<i>APC</i>mutations Marina De Rosa, Ricardo Dourisboure, Gemma Morelli, Human Mutation Genotype CharacterizationMendelian DisorderGenetic DisorderFamilial Adenomatous PolyposisGenetics	2004	29

Page 1